Balanced news tone
News Sentiment
LFCR sentiment intelligence
Lifecore Biomedical Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
76/100 classification confidence.
directly relevant articles
high-authority source matches
-6.7% over one week, -15.8% over four weeks, trend inactive, and below fair value.
New Lifecore Hire Gets 3,500 Stock Units Vesting in Three Years
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Lifecore Biomedical Inc (LFCR) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of Lifecore Biomedical Inc's (LFCR) dividend and stock split history. It indicates that the company has not distributed any dividends over the past five years and has no recorded stock split data. The page displays current stock performance and m
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 17 Jun 2026 18:40
- Source
- TradingKey
Barrington Adjusts Price Target on Lifecore Biomedical to $6.50 From $6, Maintains Outperform Rating
- Tone
- Positive 58/100
- Event
- Analyst action
- Published
- 16 Jun 2026 11:36
- Source
- MT Newswires
Lifecore Biomedical Signs Deal to Support Manufacturing of Neurology Injection Product
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 15 Jun 2026 11:42
- Source
- MT Newswires
Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 11:05
- Source
- GlobeNewswire
Seventh late-stage project adds neurology deal for Lifecore Biomedical
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 15 Jun 2026 07:00
- Source
- Stock Titan
Lifecore Biomedical (LFCR) Stock Draws Fresh Price Target Split After FY26 Outlook
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 12 Jun 2026 07:00
- Source
- Market source
Lifecore Biomedical Signs Manufacturing Services Agreement With Ophthalmic Customer
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 12:15
- Source
- MT Newswires
Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 11:05
- Source
- GlobeNewswire
Pre-filled ophthalmic injectables: Lifecore inks new manufacturing deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 02 Jun 2026 07:00
- Source
- Stock Titan
How The Lifecore Biomedical (LFCR) Narrative Is Shifting On Guidance, Timing And 2028 Expectations
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 29 May 2026 01:03
- Source
- Simply Wall St.
Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- Market source
Lifecore Biomedical Reports Financial Results for the First
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 May 2026 07:00
- Source
- GlobeNewswire
Lifecore Biomedical Q1 Earnings Call Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 May 2026 07:00
- Source
- Market source
Laughing Water Capital’s Insights on Lifecore Biomedical (LFCR)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Apr 2026 07:00
- Source
- Market source
What Triggered Lifecore Biomedical's Recent Stock Plunge
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Mar 2026 18:23
- Source
- Kavout | AI
Lifecore Biomedical Reports Financial Results for the
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Mar 2026 07:00
- Source
- GlobeNewswire
Lifecore Biomedical Shareholders Are Encouraged to Reach
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Mar 2026 07:00
- Source
- GlobeNewswire
Lifecore Biomedical (LFCR) Q4 Loss Narrows To US$2 Million Reinforcing Bullish Margin Narratives
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Mar 2026 07:00
- Source
- simplywall.st
Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) Subdued P/S Might Signal An Opportunity
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Jan 2026 08:00
- Source
- simplywall.st
Lifecore Biomedical: The Turnaround Is Just Getting Started (NASDAQ:LFCR)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jan 2026 08:00
- Source
- Seeking Alpha
Lifecore Biomedical: A Disconnect Between Share Price And Business Progress (LFCR)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Nov 2025 08:00
- Source
- Seeking Alpha
Lifecore Biomedical (NASDAQ:LFCR) Is Making Moderate Use Of Debt
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 18 Jul 2025 07:00
- Source
- simplywall.st